Steroidal sapogenins and their derivatives for treating alzheimer's disease
US6812213B2 · kind B2 · utility
3Cited by
8References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 15, 2002 |
| Grant date | Nov 2, 2004 |
| Priority date | — |
| Expiry date | Feb 15, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/944
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention discloses the use of a number of saponins and sapogenins, notably those of steroidal structure, in the treatment of cognitive disfunction and similar conditions. Methods of treatment, and pharmaceutical compositions are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.